Real-World Effectiveness of Maternal RSVpreF Vaccination and Durability of Infant Protection
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
In this test-negative study, the effectiveness of the maternal RSVpreF vaccine among infants <6 months was 73.9% against medically attended respiratory syncytial virus (RSV) infection and 86.3% against RSV-associated hospitalization. Maternal RSVpreF and nirsevimab had comparable initial effectiveness, but effectiveness of RSVpreF waned approximately 1.7 times more rapidly.
